Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery
Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery
Active, not recruiting · NCT06204159 · Registry updated 2026-06-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lipiodol Deposition Using Endhole vs. Pressure-Modulated Delivery | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Not applicable | 2026-06-11 | NCT06204159 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Abramson Cancer Center at Penn Medicine | 137 |
| TriSalus Life Sciences, Inc. | 7 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abramson Cancer Center of the University of Pennsylvania | Philadelphia | United States | 47 |
| University of Pennsylvania, Department of Radiology, Interventional Radiology Division | Philadelphia | United States | 1 |